After Hours
There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours.
Stocks Info
This NASDAQ-listed company operates within the Biotechnology industry segment, falling under the Healthcare sector. The current market capitalization of Dyne Therapeutics Inc is $1.46B. A total of 1.86 million shares were traded on the day, compared to an average of 2.90M shares.
In the most recent transaction, Cox John bought 100,000 shares of DYN for 9.11 per share on Jul 14 ’25. After the transaction, the CEO & President now owns 242,179 company shares. In a previous transaction on Jun 11 ’25, Scalzo Richard William bought 1,330 shares at 14.75 per share.
Among the insiders who bought shares, Beskrovnaya Oxana acquired of 2,132 shares on Jun 11 ’25 at a per-share price of $14.75. In another insider transaction, Cox John sold 4,060 shares at $13.35 per share on Jun 05 ’25. Company shares held by the CEO & President now total 142,179.
Even though price targets are rarely accurate, they do tend to exert some kind of influence from time to time and are often considered important by markets. In terms of 52-week highs and lows, DYN has a high of $47.45 and a low of $6.36.
Balance Sheet Annually/Quarterly
In a balance sheet, you can see what assets and liabilities the company has, as well as how much equity investors have invested. These figures can be used to calculate a company’s financial ratios to give investors a better idea of its prospects. DYN’s latest balance sheet shows that the firm has $376.57M in Cash & Short Term Investments as of fiscal 2021. There were $32.64M in debt and $28.72M in liabilities at the time. Its Book Value Per Share was $5.00, while its Total Shareholder’s Equity was $368.20M.
Analysts Opinion
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock.
